Targeted therapy involves directing therapeutic agents specifically to diseased cells, sparing healthy cells from exposure. Nanoparticles can be functionalized with ligands that bind to specific biomarkers on the surface of cancer cells or other diseased tissues. This targeted approach reduces the required dosage and minimizes damage to healthy tissues, thus improving the overall therapeutic index.
